| Mr Mark W Melecki, PT | |
|
12119 Se Stevens Ct, Happy Valley, OR 97086-2620 | |
| (503) 353-1278 | |
| (503) 353-1273 |
| Full Name | Mr Mark W Melecki |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 36 Years |
| Location | 12119 Se Stevens Ct, Happy Valley, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013128743 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 5304 (Oregon) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| H And P Goodell Inc | 1153340476 | 7 |
News Archive
Hospital quality measures do not fully account for the variation in hospital death rates for heart attack patients, according to a study in the July 5 issue of Journal of the American Medical Association.
In a new study a team of researchers have found that chemotherapy can be completely skipped in early stage breast cancer patients provided certain genetic tests of the tumours are made to assess the risk.
Boston Scientific today announced that its Close the Gap campaign is partnering with the Kirk Herbstreit National Kickoff Classic to raise awareness of heart disease risk factors for women and minorities.
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, announced today that it has submitted a Supplemental New Drug Application with the U.S. Food and Drug Administration seeking approval for the marketing and sale of Lymphoseek (technetium 99m tilmanocept) Injection for sentinel lymph node detection in patients with head and neck cancer, an indication for which Lymphoseek was also granted Fast Track designation earlier this month.
› Verified 3 days ago
| Provider Name | Northwest Primary Care Group Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1144319658 PECOS PAC ID: 0244125052 Enrollment ID: O20040219000947 |
News Archive
Hospital quality measures do not fully account for the variation in hospital death rates for heart attack patients, according to a study in the July 5 issue of Journal of the American Medical Association.
In a new study a team of researchers have found that chemotherapy can be completely skipped in early stage breast cancer patients provided certain genetic tests of the tumours are made to assess the risk.
Boston Scientific today announced that its Close the Gap campaign is partnering with the Kirk Herbstreit National Kickoff Classic to raise awareness of heart disease risk factors for women and minorities.
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, announced today that it has submitted a Supplemental New Drug Application with the U.S. Food and Drug Administration seeking approval for the marketing and sale of Lymphoseek (technetium 99m tilmanocept) Injection for sentinel lymph node detection in patients with head and neck cancer, an indication for which Lymphoseek was also granted Fast Track designation earlier this month.
› Verified 3 days ago
| Provider Name | H & P Goodell Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1013908169 PECOS PAC ID: 1153340476 Enrollment ID: O20051116000485 |
News Archive
Hospital quality measures do not fully account for the variation in hospital death rates for heart attack patients, according to a study in the July 5 issue of Journal of the American Medical Association.
In a new study a team of researchers have found that chemotherapy can be completely skipped in early stage breast cancer patients provided certain genetic tests of the tumours are made to assess the risk.
Boston Scientific today announced that its Close the Gap campaign is partnering with the Kirk Herbstreit National Kickoff Classic to raise awareness of heart disease risk factors for women and minorities.
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, announced today that it has submitted a Supplemental New Drug Application with the U.S. Food and Drug Administration seeking approval for the marketing and sale of Lymphoseek (technetium 99m tilmanocept) Injection for sentinel lymph node detection in patients with head and neck cancer, an indication for which Lymphoseek was also granted Fast Track designation earlier this month.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Mark W Melecki, PT 12119 Se Stevens Ct, Happy Valley, OR 97086-2620 Ph: (503) 353-1278 | Mr Mark W Melecki, PT 12119 Se Stevens Ct, Happy Valley, OR 97086-2620 Ph: (503) 353-1278 |
News Archive
Hospital quality measures do not fully account for the variation in hospital death rates for heart attack patients, according to a study in the July 5 issue of Journal of the American Medical Association.
In a new study a team of researchers have found that chemotherapy can be completely skipped in early stage breast cancer patients provided certain genetic tests of the tumours are made to assess the risk.
Boston Scientific today announced that its Close the Gap campaign is partnering with the Kirk Herbstreit National Kickoff Classic to raise awareness of heart disease risk factors for women and minorities.
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, announced today that it has submitted a Supplemental New Drug Application with the U.S. Food and Drug Administration seeking approval for the marketing and sale of Lymphoseek (technetium 99m tilmanocept) Injection for sentinel lymph node detection in patients with head and neck cancer, an indication for which Lymphoseek was also granted Fast Track designation earlier this month.
› Verified 3 days ago
Tai - Happy Valley Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 14679 Se Sunnyside Rd Ste A, Happy Valley, OR 97015 Phone: 503-558-0112 Fax: 503-558-0114 | |
Oregon Mobile Rehab Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 14445 Se Mountain Ridge Ave, Happy Valley, OR 97086 Phone: 503-891-4586 | |
Kaneah Owen, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 16180 Se Sunnyside Rd Ste 204, Happy Valley, OR 97015 Phone: 503-382-4600 | |
Karen Kuo, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 12119 Se Stevens Ct, Happy Valley, OR 97086 Phone: 503-353-1278 | |
Aegis Group Practice Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 12154 Se 114th Ct, Happy Valley, OR 97086 Phone: 479-201-6091 | |
Kelsy Wright, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 16126 Se Happy Valley Town Center Dr Ste 200, Happy Valley, OR 97086 Phone: 503-427-0118 Fax: 503-427-0279 |